Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

5.76
Delayed Data
As of 4:14pm ET
 -0.08 / -1.37%
Today’s Change
2.98
Today|||52-Week Range
8.59
+21.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues71.9M85.1M69.6M42.1M
 
 
 
 
 
Cost of Goods Sold20.0M19.2M25.7M41.5M
 
 
 
 
 
Depreciation And Amortization7.6M5.1M4.4M4.5M
 
 
 
 
 
 
Operating ExpensesGross Income44.3M60.9M39.5M-3.9M
 
 
 
 
 
General Expenses77.4M71.9M78.6M68.9M
 
 
 
 
 
Research And Development61.4M56.7M59.4M47.6M
 
 
 
 
 
Total Operating Expenses105.0M96.2M108.7M114.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-33.1M-11.0M-39.1M-72.8M
 
 
 
 
 
Extraordinary Credit350.0K0.00656.0K0.00
 
 
 
Extraordinary Charge-10.0M-942.0K-12.0M-2.8M
 
 
 
 
 
Interest Expense On Debt15.9M11.6M11.5M9.7M
 
 
 
 
 
Other Expenses1.9M0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-56.3M-23.6M-61.9M-85.3M
 
 
 
 
 
Net Income-56.3M-23.6M-61.9M-85.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS55.4M70.6M107.8M123.4M
 
 
 
 
 
Shares To Calculate EPS Diluted55.4M70.6M107.8M123.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.02-$0.33-$0.57-$0.69
 
 
 
 
 
EPS Diluted-$1.02-$0.33-$0.57-$0.69